Michael Shlipak, MD

UCSF/San Francisco VA Healthcare System

Disclosure(s): Astra-Zeneca: Honoraria; Bayer: Grant/Research Support, Honoraria; Boehringer Ingelheim: Honoraria

Poster(s):

• (P-2201) A Comprehensive Kidney Biomarker Panel to Assess Kidney Health after Hepatitis C Direct Acting Antiviral Therapy in Persons with HCV monoinfection and HCV/HIV coinfection
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT